1. Academic Validation
  2. Dual T cell- and B cell-intrinsic deficiency in humans with biallelic RLTPR mutations

Dual T cell- and B cell-intrinsic deficiency in humans with biallelic RLTPR mutations

  • J Exp Med. 2016 Oct 17;213(11):2413-2435. doi: 10.1084/jem.20160576.
Yi Wang 1 2 Cindy S Ma 3 4 Yun Ling 1 2 Aziz Bousfiha 5 Yildiz Camcioglu 6 Serge Jacquot 7 8 Kathryn Payne 3 Elena Crestani 9 Romain Roncagalli 10 Aziz Belkadi 1 2 Gaspard Kerner 1 2 Lazaro Lorenzo 1 2 Caroline Deswarte 1 2 Maya Chrabieh 1 2 Etienne Patin 11 12 Quentin B Vincent 1 2 Ingrid Müller-Fleckenstein 13 Bernhard Fleckenstein 13 Fatima Ailal 5 Lluis Quintana-Murci 11 12 Sylvie Fraitag 14 Marie-Alexandra Alyanakian 15 Marianne Leruez-Ville 16 Capucine Picard 1 2 17 Anne Puel 1 2 Jacinta Bustamante 1 2 17 Stéphanie Boisson-Dupuis 1 2 18 Marie Malissen 10 Bernard Malissen 10 Laurent Abel 1 2 Alain Hovnanian 19 2 Luigi D Notarangelo 9 20 Emmanuelle Jouanguy 1 2 18 Stuart G Tangye 3 4 Vivien Béziat 21 2 Jean-Laurent Casanova 1 2 22 18 23
Affiliations

Affiliations

  • 1 Laboratory of Human Genetics of Infectious Diseases, Necker Branch, Institut National de la Santé et de la Recherche Médicale U1163, 75015 Paris, France.
  • 2 Paris Descartes University, Imagine Institute, 75015 Paris, France.
  • 3 Immunology Division, Garvan Institute of Medical Research, Darlinghurst, Sydney, NSW 2010, Australia.
  • 4 St. Vincent's Clinical School, University of New South Wales, Darlinghurst, Sydney, NSW 2010, Australia.
  • 5 Clinical Immunology Unit, Casablanca Children's Hospital, Ibn Rochd Medical School, King Hassan II University, Casablanca 20100, Morocco.
  • 6 Division of Infectious Diseases, Clinical Immunology, and Allergy, Department of Pediatrics, Cerrahpaşa Medical Faculty, Istanbul University, 34452 Istanbul, Turkey.
  • 7 Immunology Unit, Rouen University Hospital, 76031 Rouen, France.
  • 8 Institut National de la Santé et de la Recherche Médicale U905, Institute for Research and Innovation in Biomedicine, Rouen Normandy University, 76183 Rouen, France.
  • 9 Division of Immunology, Boston Children's Hospital, Boston, MA 02115.
  • 10 Center for Immunology Marseille-Luminy, 13288 Marseille, France.
  • 11 Human Evolutionary Genetics Unit, Institut Pasteur, 75015 Paris, France.
  • 12 Centre National de la Recherche Scientifique URA 3012, 75015 Paris, France.
  • 13 Institute of Clinical and Molecular Virology, University of Erlangen-Nürnberg, D-91054 Erlangen, Germany.
  • 14 Department of Pathology, Necker Hospital for Sick Children, Assistance Publique - Hôpitaux de Paris, 75015 Paris, France.
  • 15 Immunology Unit, Necker Hospital for Sick Children, Assistance Publique - Hôpitaux de Paris, 75015 Paris, France.
  • 16 Virology Laboratory, Paris Descartes University, Sorbonne Paris Cité-EA 36-20, Necker Hospital for Sick Children, Assistance Publique - Hôpitaux de Paris, 75015 Paris, France.
  • 17 Center for the Study of Primary Immunodeficiencies, Necker Hospital for Sick Children, Assistance Publique - Hôpitaux de Paris, 75015 Paris, France.
  • 18 St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY 10065.
  • 19 Laboratory of Genetic Skin Diseases: from Disease Mechanism to Therapies, Institut National de la Santé et de la Recherche Médicale U1163, 75015 Paris, France.
  • 20 Harvard Stem Cell Institute, Harvard University, Cambridge, MA 02138.
  • 21 Laboratory of Human Genetics of Infectious Diseases, Necker Branch, Institut National de la Santé et de la Recherche Médicale U1163, 75015 Paris, France vivien.beziat@inserm.fr.
  • 22 Pediatric Hematology-Immunology Unit, Necker Hospital for Sick Children, Assistance Publique - Hôpitaux de Paris, 75015 Paris, France.
  • 23 Howard Hughes Medical Institute, The Rockefeller University, New York, NY 10065.
Abstract

Combined immunodeficiency (CID) refers to inborn errors of human T cells that also affect B cells because of the T cell deficit or an additional B cell-intrinsic deficit. In this study, we report six patients from three unrelated families with biallelic loss-of-function mutations in RLTPR, the mouse orthologue of which is essential for CD28 signaling. The patients have cutaneous and pulmonary allergy, as well as a variety of Bacterial and Fungal infectious diseases, including invasive tuberculosis and mucocutaneous candidiasis. Proportions of circulating regulatory T cells and memory CD4+ T cells are reduced. Their CD4+ T cells do not respond to CD28 stimulation. Their CD4+ T cells exhibit a "Th2" cell bias ex vivo and when cultured in vitro, contrasting with the paucity of "Th1," "Th17," and T follicular helper cells. The patients also display few memory B cells and poor antibody responses. This B cell phenotype does not result solely from the T cell deficiency, as the patients' B cells fail to activate NF-κB upon B cell receptor (BCR) stimulation. Human RLTPR deficiency is a CID affecting at least the CD28-responsive pathway in T cells and the BCR-responsive pathway in B cells.

Figures